The DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.
Quality-of-Life Effects of Prostate-Specific Antigen Screening
Open accessAbstract
BACKGROUND: After 11 years of follow-up, the European Randomized Study of Screening for Prostate Cancer (ERSPC) reported a 29% reduction in prostate-cancer mortality among men who underwent screening for prostate-specific antigen (PSA) levels. However, the extent to which harms to quality of life resulting from overdiagnosis and treatment counterbalance this benefit is uncertain. METHODS: On the basis of ERSPC follow-up data, we used Microsimulation Screening Analysis (MISCAN) to predict the number of prostate cancers, treatments, deaths, and quality-adjusted life-years (QALYs) gained after the introduction of PSA screening. Various screening strategies, efficacies, and quality-of-life assumptions were modeled. RESULTS: Per 1000 men of all ages who were followed for their entire life span, we predicted that annual screening of men between the ages of 55 and 69 years would result in nine fewer deaths from prostate cancer (28% reduction), 14 fewer men receiving palliative therapy (35% reduction), and a total of 73 life-years gained (average, 8.4 years per prostate-cancer death avoided). The number of QALYs that were gained was 56 (range, -21 to 97), a reduction of 23% from unadjusted life-years gained. To prevent one prostate-cancer death, 98 men would need to be screened and 5 cancers would need to be detected. Screening of all men between the ages of 55 and 74 would result in more life-years gained (82) but the same number of QALYs (56). CONCLUSIONS: The benefit of PSA screening was diminished by loss of QALYs owing to postdiagnosis long-term effects. Longer follow-up data from both the ERSPC and quality-of-life analyses are essential before universal recommendations regarding screening can be made. (Funded by the Netherlands Organization for Health Research and Development and others.).
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Screening and Prostate-Cancer Mortality in a Randomized European Study
Schröder, F. H., Hugosson, J., Roobol, M. J., Tammela, T. L. J., Ciatto, S., Nelen, V., Kwiatkowski, M., Lujan, M., Lilja, H., Zappa, M., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0810084 · Cited by 4,014
Self-citationMortality Results from a Randomized Prostate-Cancer Screening Trial
Andriole, G. L., Crawford, E. D., Grubb, R. L., Buys, S. S., Chia, D., Church, T. R., Fouad, M. N., Gelmann, E. P., Kvale, P. A., Reding, D. J., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0810696 · Cited by 2,906
Screening for Prostate Cancer: U.S. Preventive Services Task Force Recommendation Statement
Moyer, V. A., & on behalf of the U.S. Preventive Services Task Force* (2012) · Annals of Internal Medicine · doi:10.7326/0003-4819-157-2-201207170-00459 · Cited by 2,522
Quality of Life and Satisfaction with Outcome among Prostate-Cancer Survivors
Sanda, M. G., Dunn, R. L., Michalski, J., Sandler, H. M., Northouse, L., Hembroff, L., Lin, X., Greenfield, T. K., Litwin, M. S., Saigal, C. S., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa074311 · Cited by 2,253
Prostate-Cancer Mortality at 11 Years of Follow-up
Schröder, F. H., Hugosson, J., Roobol, M. J., Tammela, T. L. J., Ciatto, S., Nelen, V., Kwiatkowski, M., Lujan, M., Lilja, H., Zappa, M., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1113135 · Cited by 1,245
Self-citation20-Year Outcomes Following Conservative Management of Clinically Localized Prostate Cancer
Albertsen, P. C. (2005) · JAMA · doi:10.1001/jama.293.17.2095 · Cited by 1,187
Klotz, L., Zhang, L., Lam, A., Nam, R., Mamedov, A., & Loblaw, A. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.24.2180 · Cited by 1,074
Draisma, G., Boer, R., Otto, S. J., van der Cruijsen, I. W., Damhuis, R. A. M., Schroder, F. H., & de Koning, H. J. (2003) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/95.12.868 · Cited by 1,071
Self-citationMortality results from the Göteborg randomised population-based prostate-cancer screening trial
Hugosson, J., Carlsson, S., Aus, G., Bergdahl, S., Khatami, A., Lodding, P., Pihl, C.-G., Stranne, J., Holmberg, E., & Lilja, H. (2010) · The Lancet Oncology · doi:10.1016/s1470-2045(10)70146-7 · Cited by 936
Self-citationDraisma, G., Etzioni, R., Tsodikov, A., Mariotto, A., Wever, E., Gulati, R., Feuer, E., & de Koning, H. (2009) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djp001 · Cited by 796
Self-citationPotosky, A. L., Davis, W. W., Hoffman, R. M., Stanford, J. L., Stephenson, R. A., Penson, D. F., & Harlan, L. C. (2004) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djh259 · Cited by 680
Bill-Axelson, A., Holmberg, L., Filen, F., Ruutu, M., Garmo, H., Busch, C., Nordling, S., Haggman, M., Andersson, S.-O., Bratell, S., et al. (2008) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djn255 · Cited by 603
Damber, J.-E., & Aus, G. (2008) · The Lancet · doi:10.1016/s0140-6736(08)60729-1 · Cited by 418
Johansson, E., Steineck, G., Holmberg, L., Johansson, J.-E., Nyberg, T., Ruutu, M., & Bill-Axelson, A. (2011) · The Lancet Oncology · doi:10.1016/s1470-2045(11)70162-0 · Cited by 360
Cooperberg, M. R., Vickers, A. J., Broering, J. M., Carroll, P. R., & for the Cancer of the Prostate Strategic Urologic Research Endeavor (CaPSURE) Investigators (2010) · Cancer · doi:10.1002/cncr.25456 · Cited by 311
Prediction of Indolent Prostate Cancer: Validation and Updating of a Prognostic Nomogram
Steyerberg, E. W., Roobol, M. J., Kattan, M. W., van der Kwast, T. H., de Koning, H. J., & Schröder, F. H. (2007) · Journal of Urology · doi:10.1016/j.juro.2006.08.068 · Cited by 304
Self-citationActive Surveillance for Prostate Cancer: Progress and Promise
Cooperberg, M. R., Carroll, P. R., & Klotz, L. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2011.34.9738 · Cited by 290
A Risk-Based Strategy Improves Prostate-Specific Antigen–Driven Detection of Prostate Cancer
Roobol, M. J., Steyerberg, E. W., Kranse, R., Wolters, T., van den Bergh, R. C. N., Bangma, C. H., & Schröder, F. H. (2010) · European Urology · doi:10.1016/j.eururo.2009.08.025 · Cited by 286
Self-citationSmith, D. P., King, M. T., Egger, S., Berry, M. P., Stricker, P. D., Cozzi, P., Ward, J., O'Connell, D. L., & Armstrong, B. K. (2009) · BMJ · doi:10.1136/bmj.b4817 · Cited by 286
Boorjian, S. A., Karnes, R. J., Viterbo, R., Rangel, L. J., Bergstralh, E. J., Horwitz, E. M., Blute, M. L., & Buyyounouski, M. K. (2011) · Cancer · doi:10.1002/cncr.25900 · Cited by 272
Hayes, J. H., Ollendorf, D. A., Pearson, S. D., Barry, M. J., Kantoff, P. W., Stewart, S. T., Bhatnagar, V., Sweeney, C. J., Stahl, J. E., & McMahon, P. M. (2010) · JAMA · doi:10.1001/jama.2010.1720 · Cited by 257
Madalinska, J. B., Essink-Bot, M.-L., de Koning, H. J., Kirkels, W. J., van der Maas, P. J., & Schröder, F. H. (2001) · Journal of Clinical Oncology · doi:10.1200/jco.2001.19.6.1619 · Cited by 219
Self-citationChen, R. C., Clark, J. A., & Talcott, J. A. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.18.6486 · Cited by 199
Korfage, I. J., Essink‐Bot, M., Borsboom, G. J. J. M., Madalinska, J. B., Kirkels, W. J., Habbema, J. D. F., Schröder, F. H., & de Koning, H. J. (2005) · International Journal of Cancer · doi:10.1002/ijc.21043 · Cited by 195
Self-citationEssink-Bot, M.-L., de Koning, H. J., Nijs, H. G. T., Kirkels, W. J., van der Maas, P. J., & Schroder, F. H. (1998) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/90.12.925 · Cited by 174
Self-citationUtilities For Prostate Cancer Health States in Men Aged 60 and Older
Stewart, S. T., Lenert, L., Bhatnagar, V., & Kaplan, R. M. (2005) · Medical Care · doi:10.1097/01.mlr.0000156862.33341.45 · Cited by 169
Telesca, D., Etzioni, R., & Gulati, R. (2007) · Biometrics · doi:10.1111/j.1541-0420.2007.00825.x · Cited by 123
Patients’ perceptions of the side-effects of prostate cancer treatment—A qualitative interview study
Korfage, I. J., Hak, T., de Koning, H. J., & Essink‐Bot, M. (2006) · Social Science & Medicine · doi:10.1016/j.socscimed.2006.01.027 · Cited by 106
Self-citationThe effect of study arm on prostate cancer treatment in the large screening trial ERSPC
Wolters, T., Roobol, M. J., Steyerberg, E. W., van den Bergh, R. C. N., Bangma, C. H., Hugosson, J., Ciatto, S., Kwiatkowski, M., Villers, A. A., Lujan, M., et al. (2009) · International Journal of Cancer · doi:10.1002/ijc.24870 · Cited by 99
Self-citationZappa, M., Ciatto, S., Bonardi, R., et al. (1998) · Annals of Oncology · doi:10.1023/a:1008492013196 · Cited by 92
Self-citationLifetime implications and cost-effectiveness of using finasteride to prevent prostate cancer
Zeliadt, S. B., Etzioni, R., Penson, D. F., Thompson, I. M., & Ramsey, S. D. (2005) · The American Journal of Medicine · doi:10.1016/j.amjmed.2005.03.001 · Cited by 71
Mols, F., Korfage, I. J., Vingerhoets, A. J. J. M., Kil, P. J. M., Coebergh, J. W. W., Essink‐Bot, M., & van de Poll-Franse, L. V. (2008) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2008.04.004 · Cited by 67
Self-citationPSA-based Screening for Prostate Cancer: How Does It Compare with Other Cancer Screening Tests?
Crawford, E. D., & Abrahamsson, P. (2008) · European Urology · doi:10.1016/j.eururo.2008.05.032 · Cited by 61
Prostate cancer diagnosis: The impact on patients’ mental health
Korfage, I. J., de Koning, H. J., Roobol, M. J., Schröder, F. H., & Essink‐Bot, M. (2005) · European Journal of Cancer · doi:10.1016/j.ejca.2005.10.011 · Cited by 49
Self-citationBennett, C. L., Matchar, D. B., McCrory, D., McLeod, D. G., Crawford, E. D., & Hillner, B. E. (1996) · Cancer · doi:10.1002/(sici)1097-0142(19960501)77:9<1854::aid-cncr15>3.0.co;2-z · Cited by 46
Thong, M. S. Y., Mols, F., Kil, P. J. M., Korfage, I. J., & van de Poll-Franse, L. V. (2009) · British Journal of Urology · doi:10.1111/j.1464-410x.2009.08815.x · Cited by 46
Self-citationCooperberg, M. R., Vickers, A. J., Broering, J. M., & Carroll, P. R. (2011) · Cancer · doi:10.1002/cncr.25914 · Cited by 40
Carlsson, S., Aus, G., Bergdahl, S., et al. (2010) · European Journal of Cancer · doi:10.1016/j.ejca.2010.10.016 · Cited by 39
Self-citationKonski, A. A., Sherman, E. J., Krahn, M. D., Bremner, K. E., Beck, J. R., Bruner, D. W., & Pilepich, M. V. (2005) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2005.03.010 · Cited by 39
Pelzer, A. E., Bektić, J., Akkad, T., Ongarello, S., Schaefer, G., Schwentner, C., Frauscher, F., Bartsch, G. C., & Horninger, W. (2007) · The Journal of Urology · doi:10.1016/j.juro.2007.03.021 · Cited by 35
Penson, D. F., Ramsey, S., Veenstra, D. L., Clarke, L. D., Gandhi, S. K., & Hirsch, M. (2005) · The Journal of Urology · doi:10.1097/01.ju.0000165569.48372.4c · Cited by 34
Konski, A. A., Bruner, D. W., Brereton, H. D., Feigenberg, S. J., & Hanks, G. E. (2005) · Cancer · doi:10.1002/cncr.21575 · Cited by 30
Cited by
Breast Cancer, Version 4.2017, NCCN Clinical Practice Guidelines in Oncology
Gradishar, W. J., Anderson, B. O., Balassanian, R., Blair, S. L., Burstein, H. J., Cyr, A., Elias, A. D., Farrar, W. B., Forero, A., Giordano, S. H., et al. (2018) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2018.0012 · Cited by 1,609
Schröder, F. H., Hugosson, J., Roobol, M. J., Tammela, T. L. J., Zappa, M., Nelen, V., Kwiatkowski, M., Lujan, M., Määttänen, L., Lilja, H., et al. (2014) · The Lancet · doi:10.1016/s0140-6736(14)60525-0 · Cited by 1,566
Self-citationEarly Detection of Prostate Cancer: AUA Guideline
Carter, H. B., Albertsen, P. C., Barry, M. J., Etzioni, R., Freedland, S. J., Greene, K. L., Holmberg, L., Kantoff, P., Konety, B. R., Murad, M. H., et al. (2013) · Journal of Urology · doi:10.1016/j.juro.2013.04.119 · Cited by 1,242
Ilic, D., Neuberger, M. M., Djulbegovic, M., & Dahm, P. (2013) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004720.pub3 · Cited by 1,150
Nanoparticle Probes for the Detection of Cancer Biomarkers, Cells, and Tissues by Fluorescence
Chinen, A. B., Guan, C. M., Ferrer, J. R., Barnaby, S. N., Merkel, T. J., & Mirkin, C. A. (2015) · Chemical Reviews · doi:10.1021/acs.chemrev.5b00321 · Cited by 1,032
Metadata
- Authors
- Heijnsdijk, E. A. M., Wever, E. M., Auvinen, A., Hugosson, J., Ciatto, S., Nelen, V., Kwiatkowski, M., Villers, A., Páez, A., Moss, S. M., Zappa, M., Tammela, T. L. J., Mäkinen, T., Carlsson, S., Korfage, I. J., Essink-Bot, M.-L., Otto, S. J., Draisma, G., Bangma, C. H., Roobol, M. J., Schröder, F. H., & de Koning, H. J.
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2012-08-16
- Volume
- 367
- Issue
- 7
- Pages
- 595-605
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2116556918
- Cited by
- 427
- References
- 42
- FWCI
- 38.18
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.